Ampersand-Backed Alliance Pharma To Acquire Lgc'S Drug Development Solutions Business ("Dds") And Welcomes Kkr As Joint Shareholder
Acquiring Company
Alliance Pharma plc
Acquired Company
LGC Group
Description
Alliance Pharma, a US-based Bioanalytical CRO and an Ampersand portfolio company, has agreed to acquire DDS, a UK-based Bioanalytical Business Unit of LGC. KKR will become an equal shareholder in the combined business alongside Ampersand Capital Partners. Backed by Ampersand and KKR, Alliance and DDS plan to expand the company's geographic reach, broaden its laboratory capabilities and expand its service portfolio. The transaction is subject to regulatory approvals and expected to be completed in Q2 2022.
Quick answer
Alliance Pharma plc is acquiring LGC Group, announced May 17, 2022.
- How much did Alliance Pharma plc pay for LGC Group?
- The deal value was not disclosed.
- What does Alliance Pharma plc do?
- Alliance Pharma plc is a UK listed international consumer healthcare company targeting the markets of France, the US, Germany, China, and the UK.
Source: Fundz verified event record.
Other recent acquisitions in Professional Services and Science And Engineering
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Regeneron Completes Acquisition Of Checkmate Pharmaceuticals (May 31, 2022)
- Regeneron To Acquire Checkmate Pharmaceuticals And Its Investigational Immune Activator For Potential Use In Multiple Tumor Types (April 19, 2022)
- Consegna Pharma Acquires Fathom Pharma To Strengthen Initiatives That Address The Opioid Crisis (April 19, 2022)
- Bristol Myers Squibb To Acquire Turning Point Therapeutics, A Leading Precision Oncology Company (June 3, 2022)
- Halozyme Completes Antares Pharma Acquisition (May 24, 2022)
- Aprea Therapeutics Announces Acquisition Of Atrin Pharmaceuticals Inc. And Reports First Quarter 2022 Financial Results (May 16, 2022)
Who to call at Alliance Pharma plc, and when
When Alliance Pharma plc changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Alliance Pharma plc raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Alliance Pharma plc, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Alliance Pharma plc. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Alliance Pharma plc makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired LGC Group?
LGC Group was acquired by Alliance Pharma plc. The deal was reported on May 17, 2022. Alliance Pharma plc is a UK listed international consumer healthcare company targeting the markets of France, the US, Germany, China, and the UK. Alliance Pharma plc is privately held and operates in Biotechnology.
When did Alliance Pharma plc acquire LGC Group?
Alliance Pharma plc's acquisition of LGC Group was reported on May 17, 2022. Alliance Pharma, a US-based Bioanalytical CRO and an Ampersand portfolio company, has agreed to acquire DDS, a UK-based Bioanalytical Business Unit of LGC. KKR will become an equal shareholder in the combined business alongside Ampersand Capital Partners. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does LGC Group do?
LGC Group is a global leader in life sciences, specializing in the synthesis of complex organic molecules crucial for drug discovery, forensic testing, and environmental safety. It is privately held, operating in Biotechnology.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.